Literature DB >> 20976448

Mechanism of synergistic effect of chemotherapy and immunotherapy of cancer.

Rupal Ramakrishnan1, Dmitry I Gabrilovich.   

Abstract

In recent years, the combination of cancer immunotherapy with standard therapeutic modality is gaining credibility due to a number of clinical trials demonstrating therapeutic success of such combination therapies. However, the mechanism of this phenomenon is poorly understood. Here, we will discuss recent findings that suggest novel mechanisms of synergistic effect of cancer immunotherapy and chemotherapy.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20976448     DOI： 10.1007/s00262-010-0930-1

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN： 0340-7004            Impact factor:   6.968


  24 in total

Review 1.  The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors.

Authors:  James W Hodge; Andressa Ardiani; Benedetto Farsaci; Anna R Kwilas; Sofia R Gameiro
Journal:  Semin Oncol       Date:  2012-06       Impact factor: 4.929

Review 2.  Therapeutic Implications of the Molecular and Immune Landscape of Triple-Negative Breast Cancer.

Authors:  Ana C Gregório; Manuela Lacerda; Paulo Figueiredo; Sérgio Simões; Sérgio Dias; João Nuno Moreira
Journal:  Pathol Oncol Res       Date:  2017-09-14       Impact factor: 3.201

3.  Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapy.

Authors:  Steven Eric Finkelstein; Francisco Rodriguez; Mary Dunn; Mary-Jane Farmello; Renee Smilee; William Janssen; Loveleen Kang; Tian Chuang; John Seigne; Julio Pow-Sang; Javier F Torres-Roca; Randy Heysek; Matt Biagoli; Ravi Shankar; Jacob Scott; Scott Antonia; Dmitry Gabrilovich; Mayer Fishman
Journal:  Immunotherapy       Date:  2012-04       Impact factor: 4.196

4.  An Immune-Related lncRNA Signature to Predict the Biochemical Recurrence and Immune Landscape in Prostate Cancer.

Authors:  Guian Zhang; Yong Luo
Journal:  Int J Gen Med       Date:  2021-11-30

5.  Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer.

Authors:  Cristina Iclozan; Scott Antonia; Alberto Chiappori; Dung-Tsa Chen; Dmitry Gabrilovich
Journal:  Cancer Immunol Immunother       Date:  2013-04-16       Impact factor: 6.968

Review 6.  Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges.

Authors:  Alyssa Master; Megan Livingston; Anirban Sen Gupta
Journal:  J Control Release       Date:  2013-03-06       Impact factor: 9.776

7.  Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapy.

Authors:  Indu R Ramachandran; Thomas Condamine; Cindy Lin; Sarah E Herlihy; Alfred Garfall; Dan T Vogl; Dmitry I Gabrilovich; Yulia Nefedova
Journal:  Cancer Lett       Date:  2015-11-27       Impact factor: 8.679

8.  Targeted codelivery of doxorubicin and IL-36γ expression plasmid for an optimal chemo-gene combination therapy against cancer lung metastasis.

Authors:  Yichao Chen; Jingjing Sun; Yixian Huang; Yanhua Liu; Lei Liang; Da Yang; Binfeng Lu; Song Li
Journal:  Nanomedicine       Date:  2018-10-08       Impact factor: 5.307

Review 9.  Current immunotherapeutic approaches in pancreatic cancer.

Authors:  Shigeo Koido; Sadamu Homma; Akitaka Takahara; Yoshihisa Namiki; Shintaro Tsukinaga; Jimi Mitobe; Shunichi Odahara; Toyokazu Yukawa; Hiroshi Matsudaira; Keisuke Nagatsuma; Kan Uchiyama; Kenichi Satoh; Masaki Ito; Hideo Komita; Hiroshi Arakawa; Toshifumi Ohkusa; Jianlin Gong; Hisao Tajiri
Journal:  Clin Dev Immunol       Date:  2011-09-14

10.  Prognostic and predictive value of PDL1 expression in breast cancer.

Authors:  Renaud Sabatier; Pascal Finetti; Emilie Mamessier; José Adelaide; Max Chaffanet; Hamid Raza Ali; Patrice Viens; Carlos Caldas; Daniel Birnbaum; François Bertucci
Journal:  Oncotarget       Date:  2015-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.